GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nextbiomedical Co Ltd (XKRX:389650) » Definitions » Dividends per Share

Nextbiomedical Co (XKRX:389650) Dividends per Share : ₩0.00 (TTM As of Dec. 2023)


View and export this data going back to 2024. Start your Free Trial

What is Nextbiomedical Co Dividends per Share?

Nextbiomedical Co's dividends per share for the six months ended in Dec. 2023 was ₩0.00. Its dividends per share for the trailing twelve months (TTM) ended in Dec. 2023 was ₩0.00. Its Dividend Payout Ratio for the six months ended in Dec. 2023 was 0.00. As of today, Nextbiomedical Co's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Nextbiomedical Co Dividends per Share Historical Data

The historical data trend for Nextbiomedical Co's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nextbiomedical Co Dividends per Share Chart

Nextbiomedical Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Dividends per Share
- - - -

Nextbiomedical Co Semi-Annual Data
Dec20 Dec21 Dec22 Dec23
Dividends per Share - - - -

Competitive Comparison of Nextbiomedical Co's Dividends per Share

For the Biotechnology subindustry, Nextbiomedical Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nextbiomedical Co's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nextbiomedical Co's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Nextbiomedical Co's Dividend Yield % falls into.



Nextbiomedical Co Dividends per Share Calculation

Dividends paid to per common share.


Nextbiomedical Co  (XKRX:389650) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Nextbiomedical Co's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2023 )/ EPS without NRI (Q: Dec. 2023 )
=0/ -1203.345
=N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nextbiomedical Co Dividends per Share Related Terms

Thank you for viewing the detailed overview of Nextbiomedical Co's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Nextbiomedical Co Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Venture-ro, No. 6, 100 beongil, Yeonsu-gu, Incheon, KOR
Nextbiomedical Co Ltd is an bio-solution company. The company develops and commercializes therapeutic agents for treating diseases based on polymer and drug delivery system technology. The company has developed products that include endoscopic hemostatic agents, vascular embolic microspheres, and others.

Nextbiomedical Co Headlines

No Headlines